2021 Q2 Form 10-Q Financial Statement

#000079923321000040 Filed on August 06, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $154.1M $160.9M
YoY Change -4.23% 13.2%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $103.5M $105.9M
YoY Change -2.29% 13.99%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $25.98M $27.20M
YoY Change -4.5% 19.3%
% of Gross Profit
Operating Expenses $134.6M $139.1M
YoY Change -3.21% 15.34%
Operating Profit $27.35M $24.99M
YoY Change 9.45% -13.92%
Interest Expense $0.00 $200.0K
YoY Change -100.0% -83.33%
% of Operating Profit 0.0% 0.8%
Other Income/Expense, Net
YoY Change
Pretax Income $27.53M $25.15M
YoY Change 9.46% -16.9%
Income Tax $6.784M $5.964M
% Of Pretax Income 24.65% 23.72%
Net Earnings $20.74M $19.18M
YoY Change 8.13% -14.22%
Net Earnings / Revenue 13.46% 11.92%
Basic Earnings Per Share $0.26 $0.24
Diluted Earnings Per Share $0.26 $0.24
COMMON SHARES
Basic Shares Outstanding 79.91M shares 81.35M shares
Diluted Shares Outstanding 79.96M shares 81.42M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $167.2M $82.50M
YoY Change 102.72% -59.87%
Cash & Equivalents $167.2M $82.46M
Short-Term Investments
Other Short-Term Assets $12.21M $15.16M
YoY Change -19.46% 26.56%
Inventory
Prepaid Expenses
Receivables $59.29M $64.13M
Other Receivables $0.00 $0.00
Total Short-Term Assets $247.5M $169.6M
YoY Change 45.9% -39.52%
LONG-TERM ASSETS
Property, Plant & Equipment $500.4M $543.5M
YoY Change -7.93% 32.3%
Goodwill $168.3M $168.3M
YoY Change 0.0% 27.11%
Intangibles $23.55M $25.94M
YoY Change -9.21% 95.18%
Long-Term Investments
YoY Change
Other Assets $17.25M $17.83M
YoY Change -3.26% 1.05%
Total Long-Term Assets $709.5M $760.9M
YoY Change -6.75% 31.33%
TOTAL ASSETS
Total Short-Term Assets $247.5M $169.6M
Total Long-Term Assets $709.5M $760.9M
Total Assets $957.0M $930.5M
YoY Change 2.85% 8.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.95M $15.90M
YoY Change 19.19% -33.19%
Accrued Expenses $57.18M $55.10M
YoY Change 3.77% 5.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $77.22M $71.53M
YoY Change 7.95% -6.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $47.53M $54.10M
YoY Change -12.15% 0.93%
Total Long-Term Liabilities $138.0M $156.4M
YoY Change -11.74% 20.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.22M $71.53M
Total Long-Term Liabilities $138.0M $156.4M
Total Liabilities $215.2M $227.9M
YoY Change -5.56% 10.35%
SHAREHOLDERS EQUITY
Retained Earnings $922.2M $855.8M
YoY Change 7.76% 7.43%
Common Stock $5.438M $5.513M
YoY Change -1.36% 17.15%
Preferred Stock
YoY Change
Treasury Stock (at cost) $185.9M $158.7M
YoY Change 17.13% 7.22%
Treasury Stock Shares 10.78M shares 9.333M shares
Shareholders Equity $741.8M $702.6M
YoY Change
Total Liabilities & Shareholders Equity $957.0M $930.5M
YoY Change 2.85% 8.22%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $20.74M $19.18M
YoY Change 8.13% -14.22%
Depreciation, Depletion And Amortization $25.98M $27.20M
YoY Change -4.5% 19.3%
Cash From Operating Activities $27.38M $43.70M
YoY Change -37.36% 21.73%
INVESTING ACTIVITIES
Capital Expenditures -$37.79M -$40.70M
YoY Change -7.16% 26.01%
Acquisitions
YoY Change
Other Investing Activities $30.66M $16.40M
YoY Change 86.93% -34.4%
Cash From Investing Activities -$7.229M -$24.30M
YoY Change -70.25% 237.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.630M -1.700M
YoY Change -4.12% 466.67%
NET CHANGE
Cash From Operating Activities 27.38M 43.70M
Cash From Investing Activities -7.229M -24.30M
Cash From Financing Activities -1.630M -1.700M
Net Change In Cash 18.52M 17.70M
YoY Change 4.61% -37.68%
FREE CASH FLOW
Cash From Operating Activities $27.38M $43.70M
Capital Expenditures -$37.79M -$40.70M
Free Cash Flow $65.16M $84.40M
YoY Change -22.8% 23.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
HEARTLAND EXPRESS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000799233
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79490314 shares
dei Entity Shell Company
EntityShellCompany
false
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1100000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1100000 USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
395000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
395000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90689000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
90689000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79913000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80653000 shares
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
10776000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
10036000 shares
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
15608000 USD
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
100000 USD
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Entity File Number
EntityFileNumber
0-15087
dei Entity Registrant Name
EntityRegistrantName
HEARTLAND EXPRESS INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
93-0926999
dei Entity Address Address Line1
EntityAddressAddressLine1
901 Heartland Way,
dei Entity Address City Or Town
EntityAddressCityOrTown
North Liberty,
dei Entity Address State Or Province
EntityAddressStateOrProvince
IA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
52317
dei City Area Code
CityAreaCode
319
dei Local Phone Number
LocalPhoneNumber
626-3600
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
HTLD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
79490314 shares
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113852000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59290000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
55577000 USD
CY2021Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
8768000 USD
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
8241000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
12212000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
15342000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
247511000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
193012000 USD
CY2021Q2 us-gaap Land And Land Improvements
LandAndLandImprovements
83123000 USD
CY2020Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
77525000 USD
CY2021Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
87730000 USD
CY2020Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
86712000 USD
CY2021Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
5142000 USD
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4807000 USD
CY2021Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
14766000 USD
CY2020Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
14380000 USD
CY2021Q2 htld Revenue Equipment
RevenueEquipment
542533000 USD
CY2020Q4 htld Revenue Equipment
RevenueEquipment
590153000 USD
CY2021Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
11597000 USD
CY2020Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
5783000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
744891000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
779360000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
244510000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
240080000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
500381000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
539280000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
168295000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
168295000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23550000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
24746000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
0 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8164000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17248000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17679000 USD
CY2021Q2 us-gaap Assets
Assets
956985000 USD
CY2020Q4 us-gaap Assets
Assets
951176000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
18952000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12751000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24002000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22422000 USD
CY2021Q2 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
14521000 USD
CY2020Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
15837000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
18654000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
18557000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1090000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1475000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
77219000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71042000 USD
CY2021Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5306000 USD
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
5801000 USD
CY2021Q2 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
90471000 USD
CY2020Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
104004000 USD
CY2021Q2 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
42223000 USD
CY2020Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
45995000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
138000000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
155800000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
14398000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
907000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
907000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4531000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4330000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
922249000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
890970000 USD
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
185921000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
171873000 USD
CY2021Q2 htld Stockholders Equity Attributable To Parent2
StockholdersEquityAttributableToParent2
741766000 USD
CY2020Q4 htld Stockholders Equity Attributable To Parent2
StockholdersEquityAttributableToParent2
724334000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
956985000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
951176000 USD
CY2021Q2 us-gaap Revenues
Revenues
154128000 USD
CY2020Q2 us-gaap Revenues
Revenues
160873000 USD
us-gaap Revenues
Revenues
306530000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
534000 USD
htld Rent And Purchased Transportation
RentAndPurchasedTransportation
2636000 USD
CY2021Q2 us-gaap Fuel Costs
FuelCosts
24804000 USD
CY2020Q2 us-gaap Fuel Costs
FuelCosts
18287000 USD
us-gaap Revenues
Revenues
327191000 USD
CY2021Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
62931000 USD
CY2020Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
68147000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
127713000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
138401000 USD
CY2021Q2 htld Rent And Purchased Transportation
RentAndPurchasedTransportation
1009000 USD
CY2020Q2 htld Rent And Purchased Transportation
RentAndPurchasedTransportation
1028000 USD
htld Rent And Purchased Transportation
RentAndPurchasedTransportation
1973000 USD
us-gaap Fuel Costs
FuelCosts
48961000 USD
us-gaap Fuel Costs
FuelCosts
44228000 USD
CY2021Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5670000 USD
CY2020Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7597000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
11358000 USD
CY2020Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6056000 USD
CY2021Q2 us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
3413000 USD
CY2020Q2 us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
3724000 USD
us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
7034000 USD
us-gaap Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
7566000 USD
CY2021Q2 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
4678000 USD
CY2020Q2 us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
5852000 USD
us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
10117000 USD
us-gaap Operating Insurance And Claims Costs Production
OperatingInsuranceAndClaimsCostsProduction
11206000 USD
CY2021Q2 us-gaap Direct Communications And Utilities Costs
DirectCommunicationsAndUtilitiesCosts
967000 USD
CY2020Q2 us-gaap Direct Communications And Utilities Costs
DirectCommunicationsAndUtilitiesCosts
1272000 USD
us-gaap Direct Communications And Utilities Costs
DirectCommunicationsAndUtilitiesCosts
2193000 USD
us-gaap Direct Communications And Utilities Costs
DirectCommunicationsAndUtilitiesCosts
2692000 USD
CY2021Q2 htld Depreciationandamortizationexcludingdepreciationoncommunicationequipment
Depreciationandamortizationexcludingdepreciationoncommunicationequipment
25956000 USD
CY2020Q2 htld Depreciationandamortizationexcludingdepreciationoncommunicationequipment
Depreciationandamortizationexcludingdepreciationoncommunicationequipment
27168000 USD
htld Depreciationandamortizationexcludingdepreciationoncommunicationequipment
Depreciationandamortizationexcludingdepreciationoncommunicationequipment
52882000 USD
htld Depreciationandamortizationexcludingdepreciationoncommunicationequipment
Depreciationandamortizationexcludingdepreciationoncommunicationequipment
53803000 USD
CY2021Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
5204000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27351000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
42314000 USD
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
175000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
10756000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
12965000 USD
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
7855000 USD
CY2020Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3247000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
12088000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3018000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
126777000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
135884000 USD
us-gaap Costs And Expenses
CostsAndExpenses
260899000 USD
us-gaap Costs And Expenses
CostsAndExpenses
284877000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
24989000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
45631000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
157000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
312000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5964000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11466000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10428000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27526000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25146000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
45943000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
42848000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6784000 USD
CY2021Q2 htld Net Income
NetIncome
20742000 USD
CY2020Q2 htld Net Income
NetIncome
19182000 USD
htld Net Income
NetIncome
34477000 USD
htld Net Income
NetIncome
32420000 USD
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20742000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19182000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34477000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32420000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79906000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81351000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80028000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81611000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79957000 shares
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81415000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80081000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81680000 shares
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.04
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.04
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
724334000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
13734000 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1599000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
14537000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
485000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
722417000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
20742000 USD
CY2021Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1598000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
205000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
741766000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
684659000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
13238000 USD
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1628000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12278000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
697000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
684688000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
19182000 USD
CY2020Q2 us-gaap Dividends Common Stock
DividendsCommonStock
1628000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
373000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
702615000 USD
htld Net Income
NetIncome
34477000 USD
htld Net Income
NetIncome
32420000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
52977000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54048000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
5369000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-9304000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
800000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1357000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
12088000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
3018000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3713000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
7380000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2073000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3318000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5502000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-222000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-880000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
567000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62775000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83758000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
56030000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
18838000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47585000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
82769000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
174000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-43000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8271000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63888000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3198000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3256000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
110000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
287000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
15022000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12278000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18330000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15821000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
52716000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4049000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131140000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96076000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
183856000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100125000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17715000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
557000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6415000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5731000 USD
htld Soldrevenueequipmentinothercurrentassets
Soldrevenueequipmentinothercurrentassets
1516000 USD
htld Soldrevenueequipmentinothercurrentassets
Soldrevenueequipmentinothercurrentassets
2017000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
167241000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82457000 USD
CY2021Q2 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
1007000 USD
CY2020Q2 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
1391000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
15608000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
16277000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
183856000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100125000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Use Of Estimates
UseOfEstimates
Use of EstimatesThe preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segments
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1200000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1100000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Revenues
Revenues
154100000 USD
CY2020Q2 us-gaap Revenues
Revenues
160900000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2800000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3400000 USD
us-gaap Revenues
Revenues
306500000 USD
us-gaap Revenues
Revenues
327200000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5900000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6900000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
16600000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
15600000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
17300000 USD
CY2020Q4 us-gaap Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
1100000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
16200000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
htld Amortization Period Of Tires
AmortizationPeriodOfTires
two years
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
1500000 USD
CY2020 us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
3400000 USD
CY2021Q2 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
41200000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17650000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23550000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 htld Net Income Loss Eps
NetIncomeLossEPS
20742000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79906000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
51000 shares
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
20742000 USD
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79957000 shares
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2020Q2 htld Net Income Loss Eps
NetIncomeLossEPS
19182000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81351000 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2020Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
64000 shares
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
19182000 USD
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81415000 shares
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
htld Net Income Loss Eps
NetIncomeLossEPS
34477000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80028000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
CY2021Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2020Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
53000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
34477000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80081000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
htld Net Income Loss Eps
NetIncomeLossEPS
32420000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81611000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0 USD
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
69000 shares
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
32420000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81680000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2021Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
4700000 shares
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
800000 shares
CY2021Q2 htld Restricted Stock Shares Authorized
RestrictedStockSharesAuthorized
600000 shares
htld Treasury Stock Value Acquired
TreasuryStockValueAcquired
14500000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
700000 shares
htld Treasury Stock Value Acquired
TreasuryStockValueAcquired
12300000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1600000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1600000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3200000 USD
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3300000 USD
CY2011Q3 htld Restricted Stock Shares Authorized
RestrictedStockSharesAuthorized
900000 shares
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
200000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
800000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
400000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1400000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
200000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y7M6D
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
44200 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
53700 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.95
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
0 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
9500 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
20.52
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.83
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
73800 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.66
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
0 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
14500 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
19.84
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
59300 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.87
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
59700 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.29
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
19300 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
34800 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
19.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
44200 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
19.83
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
52100 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
60200 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
52500 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
20.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
500 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
19.32
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
59300 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.87
CY2013Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
250000000.0 USD
CY2016Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
175000000.0 USD
CY2021Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
100000000.0 USD
CY2013Q4 htld Allowable Amount For Issuanceof Lettersof Credit
AllowableAmountForIssuanceofLettersofCredit
20000000.0 USD
CY2021Q2 htld Allowable Amount For Issuanceof Lettersof Credit
AllowableAmountForIssuanceofLettersofCredit
30000000.0 USD
htld Debt Instrument Covenant Leverage Ratio
DebtInstrumentCovenantLeverageRatio
2
htld Debt Covenant Minimum Net Income Requirement
DebtCovenantMinimumNetIncomeRequirement
1.00 USD
htld Debt Covenant Minimum Tangible Net Worth
DebtCovenantMinimumTangibleNetWorth
250000000.0 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Line Of Credit
LineOfCredit
0 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
11100000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.250
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
88900000 USD
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.246
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4600000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4900000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3600000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3900000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
100000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
0 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
400000 USD
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
100000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
700000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
900000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-100000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-100000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-100000 USD
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-100000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4937000 USD
us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
354000 USD
us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
179000 USD
us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
533000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4579000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021Q2 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
61700000 USD
htld Repurchase Of Common Stock Shares
RepurchaseOfCommonStockShares
400000 shares
htld Payments For Repurchase Of Common Stock1
PaymentsForRepurchaseOfCommonStock1
7200000 USD
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30

Files In Submission

Name View Source Status
0000799233-21-000040-index-headers.html Edgar Link pending
0000799233-21-000040-index.html Edgar Link pending
0000799233-21-000040.txt Edgar Link pending
0000799233-21-000040-xbrl.zip Edgar Link pending
exhibit3112021q2.htm Edgar Link pending
exhibit3122021q2.htm Edgar Link pending
exhibit3212021q2.htm Edgar Link pending
exhibit3222021q2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
htld-20210630.htm Edgar Link pending
htld-20210630.xsd Edgar Link pending
htld-20210630_cal.xml Edgar Link unprocessable
htld-20210630_def.xml Edgar Link unprocessable
htld-20210630_htm.xml Edgar Link completed
htld-20210630_lab.xml Edgar Link unprocessable
htld-20210630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending